{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T09:31:10Z","timestamp":1749547870286},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T00:00:00Z","timestamp":1346112000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Hepatitis C virus (HCV) infection is one of the leading causes of chronic liver disease (CLD). About 80% of those exposed to the virus develop a chronic infection. Hyperhomocysteinemia, which is an independent risk factor for atherosclerotic vascular disease and thromboembolism<jats:underline>,<\/jats:underline> may develop in HCV-infected patients although altered alanine amino transferase (ALT) enzyme levels are generally associated with damage to liver cells. The gold standard therapy for chronic hepatitis C patients is pegylated interferon combined with an anti-viral drug (ribavirin). The current study aimed to investigate the effect of antiviral therapy on plasma homocysteine (Hcy) levels in HCV patients in addition to other parameters.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>532 HCV-infected patients and 70 healthy controls were recruited for the study. All patients were subjected to laboratory investigations including HCV-RNA levels, complete blood cell counts, serum levels of homocysteine, ALT, alkaline phosphatase (ALP), lipid profile and liver ultrasonographic examination. The outcome of treatment with pegylated interferon \u03b1 plus ribavirin treatment and sustained virologic response (SVR) was determined 6\u20139\u2009months post-therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Hyperhomocysteinemia was found in 91.35% of HCV-infected patients. The difference in plasma Hcy concentrations reached statistical significance between the patient and control groups. ALT, cholesterol and triglycerides (TGs) levels were found higher than normal in the patients group. After receiving a combined therapy for 24\u2009weeks, 43.66% patients showed an SVR (responders); 30.98% patients were non-responders while 25.35% patients initially responded to therapy but again retrieved positive status of HCV infection six months post-therapy (relapse-cirrhotic patients). The mean levels of plasma Hcy, ALT and ALP were significantly reduced in responders within 10\u2009weeks of therapy when compared with non-responders and relapse-cirrhotic patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Elevated homocysteine levels in serum due to HCV infection can be reduced to normal range with the standard interferon \u03b1 plus ribavirin treatment. This study highlights the significance of the measurement of serum homocysteine levels in the diagnosis and monitoring of HCV infection treatment in addition to other laboratory parameters.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-230x-12-117","type":"journal-article","created":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T06:15:06Z","timestamp":1346134506000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Study of the effect of antiviral therapy on homocysteinemia in hepatitis C virus- infected patients"],"prefix":"10.1186","volume":"12","author":[{"given":"Mubin","family":"Mustafa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleem","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman Akbar","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Raza","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,28]]},"reference":[{"key":"870_CR1","doi-asserted-by":"publisher","first-page":"2S","DOI":"10.1002\/hep.510260701","volume":"26","author":"National Institutes of Health Consensus Development Conference Panel statement","year":"1997","unstructured":"National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C. Hepatology. 1997, 26: 2S-10S.","journal-title":"Hepatology"},{"key":"870_CR2","first-page":"1351","volume":"81","author":"T Wilkins","year":"2010","unstructured":"Wilkins T, Malcolm JK, Raina D, Schade RR: Hepatitis C: diagnosis and treatment. Am Fam Physician. 2010, 81: 1351-1357.","journal-title":"Am Fam Physician"},{"key":"870_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0272-2712(01)00002-6","volume":"22","author":"MD Burke","year":"2002","unstructured":"Burke MD: Liver function: test selection and interpretation of results. Clin Lab Med. 2002, 22: 377-390. 10.1016\/S0272-2712(01)00002-6.","journal-title":"Clin Lab Med"},{"key":"870_CR4","first-page":"755","volume":"45","author":"K Taha","year":"2009","unstructured":"Taha K, El-Shayeb A, Shafeh R, Deghady A, Eldin SZ: Clinical significance of plasma homocysteine concentration in chronic hepatitis C patients with liver cirrhosis. Bull Alex Fac Med. 2009, 45: 755-760.","journal-title":"Bull Alex Fac Med"},{"key":"870_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0399-8320(07)89402-4","volume":"31","author":"X Roblin","year":"2007","unstructured":"Roblin X, Pofelski J, Zarski JP: Steatosis, chronic hepatitis virus C infection and homocysteine. Gastroenterol Clin Biol. 2007, 31: 415-720. 10.1016\/S0399-8320(07)89402-4.","journal-title":"Gastroenterol Clin Biol"},{"key":"870_CR6","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1161\/hy1101.099499","volume":"38","author":"ER Garc\u00eda-Tevijano","year":"2001","unstructured":"Garc\u00eda-Tevijano ER, Berasain C, Rodr\u00edguez JA, Corrales FJ, Arias R, Mart\u00edn-Duce A, Caballer\u00eda J, Mato JM, Avila MA: Hyperhomocysteinemia in Liver Cirrhosis: Mechanisms and Role in Vascular and Hepatic Fibrosis. Hypertension. 2001, 38: 1217-1221. 10.1161\/hy1101.099499.","journal-title":"Hypertension"},{"key":"870_CR7","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/ajcn\/77.5.1094","volume":"77","author":"JD Finkelstein","year":"2003","unstructured":"Finkelstein JD: Methionine metabolism in liver diseases. Am J Clin Nutr. 2003, 77: 1094-1095.","journal-title":"Am J Clin Nutr"},{"key":"870_CR8","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0168-8278(00)80122-1","volume":"33","author":"MA Avila","year":"2000","unstructured":"Avila MA, Berasain C, Torres L: Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J Hepatol. 2000, 33: 907-914. 10.1016\/S0168-8278(00)80122-1.","journal-title":"J Hepatol"},{"key":"870_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1053\/jhep.2001.25882","volume":"34","author":"M Blackmund","year":"2001","unstructured":"Blackmund M, Meyer K, Von Zielonka M: Treatment of hepatitis C infection in injection drug users. Hepatol. 2001, 34: 188-193.","journal-title":"Hepatol"},{"key":"870_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJM200107193450312","volume":"345","author":"GL Davis","year":"2001","unstructured":"Davis GL, Rodrigue JR: Treatment of chronic hepatitis C in active drug users. New Engl J Med. 2001, 345: 215-217. 10.1056\/NEJM200107193450312.","journal-title":"New Engl J Med"},{"key":"870_CR11","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/ajcn\/77.5.1269","volume":"77","author":"A Bosy-Westphal","year":"2003","unstructured":"Bosy-Westphal A, Ruschmeyer M, Czech N, Oehler G, Hinrichsen H, Plauth M, Lotterer E, Fleig W, Muller MJ: Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation. Am J Clin Nutr. 2003, 77: 1269-1277.","journal-title":"Am J Clin Nutr"},{"key":"870_CR12","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.3748\/wjg.15.5647","volume":"15","author":"Y Waheed","year":"2009","unstructured":"Waheed Y, Shafi T, Safi SZ, Qadri I: Hepatitis C virus in Pakistan: A systematic review of prevalence, genotypes and risk factors. World J Gastroenterol. 2009, 15: 5647-5653. 10.3748\/wjg.15.5647.","journal-title":"World J Gastroenterol"},{"key":"870_CR13","first-page":"693","volume":"69","author":"I Halifeoglu","year":"2004","unstructured":"Halifeoglu I, Gur B, Aydin S: Plasma trace elements, vitamin B12, folate and homocysteine levels in cirrhotic patients compared to controls. Biochem. 2004, 69: 693-696.","journal-title":"Biochem"},{"key":"870_CR14","first-page":"1448","volume":"20","author":"M Gulsen","year":"2005","unstructured":"Gulsen M, Yesilova Z, Bagci S, Uygun A, Ozcan A, Ercin CN, Erdil A, Sanisoglu SY, Cakir E, Ates Y, Erbil MK, Karaeren N, Dagalp K: Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease. Hepatol. 2005, 20: 1448-1455.","journal-title":"Hepatol"},{"key":"870_CR15","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1056\/NEJMoa011232","volume":"345","author":"E Jaeckel","year":"2001","unstructured":"Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel H, Dietrich M, Trautwein C, Manns MP: Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med. 2001, 345: 1452-1457. 10.1056\/NEJMoa011232.","journal-title":"N Engl J Med"},{"key":"870_CR16","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1172\/JCI11596","volume":"107","author":"GH Werstuck","year":"2001","unstructured":"Werstuck GH, Lentz SR, Dayal S: Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest. 2001, 107: 1263-1267. 10.1172\/JCI11596.","journal-title":"J Clin Invest"},{"key":"870_CR17","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1001\/jama.1991.03470100067035","volume":"266","author":"S Baron","year":"1991","unstructured":"Baron S, Tyring SK, Fleischmann WR, Coppenhaver DH, Niesel DW, Klimpel GR, et al: The interferons: mechanisms of action and clinical applications. JAMA. 1991, 266: 1375-1383. 10.1001\/jama.1991.03470100067035.","journal-title":"JAMA"},{"key":"870_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0168-8278(05)80018-2","volume":"18","author":"F Capra","year":"1993","unstructured":"Capra F, Casaril M, Gabrielli GB, Tognella P, Rizzi A, Dolci L, Colombardi R: \u03b1-Interferon in the treatment of chronic viral hepatitis: effects on fibrogenesis serum markers. J Hepatol. 1993, 18: 112-118. 10.1016\/S0168-8278(05)80018-2.","journal-title":"J Hepatol"},{"key":"870_CR19","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/hep.1840180610","volume":"18","author":"N Manabe","year":"1993","unstructured":"Manabe N, Chevallier M, Chossegros P, Causse X, Guerret S, Trepo C, Grimaud JA: Interferon-\u03b12b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: a quantitative histological evaluation. Hepatol. 1993, 18: 1344-1349. 10.1002\/hep.1840180610.","journal-title":"Hepatol"},{"key":"870_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0168-8278(95)80420-X","volume":"22","author":"N Hiramatsu","year":"1995","unstructured":"Hiramatsu N, Hayashi N, Kasahara A, Hagiwara H, Takehara T, Haruna Y, Naito M, Fusamoto H, Kamada T: Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alpha. J Hepatol. 1995, 22: 135-142. 10.1016\/0168-8278(95)80420-X.","journal-title":"J Hepatol"},{"key":"870_CR21","first-page":"1351","volume":"22","author":"G Yamada","year":"1995","unstructured":"Yamada G, Takatani M, Kishi F, Takahashi M, Doi T, Tsuji T, Shin S, Tanno M, Urdea MS, Kolberg JA: Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level. Hepatol. 1995, 22: 1351-1354.","journal-title":"Hepatol"},{"key":"870_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1440-1746.1996.tb00054.x","volume":"11","author":"T Kumada","year":"1996","unstructured":"Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, Kiriyama S, Toyoda H, Sasa T, Shibata M, Marishiba T, Nakano I, Fukuda Y, Tameda Y, Nakashima M: Long-term administration of natural interferon-\u03b1 in patients with chronic hepatitis C: Relationship to serum RNA concentration, HCV-RNA genotypes, histological changes and hepatitis C virus. J Gastroenterol Hepatol. 1996, 11: 159-165. 10.1111\/j.1440-1746.1996.tb00054.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"870_CR23","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","volume":"358","author":"MP Manns","year":"2001","unstructured":"Manns MP, McHutchison JG, Gordon SC: Peginterferon alfa-2b in combination with ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: results of a randomized trial. Lancet. 2001, 358: 958-965. 10.1016\/S0140-6736(01)06102-5.","journal-title":"Lancet"},{"key":"870_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1161\/hq1201.100456","volume":"22","author":"N Weiss","year":"2002","unstructured":"Weiss N, Heydrick S, Zhang YY: Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice. Asterioscler Thromb Vasc Biol. 2002, 22: 34-41. 10.1161\/hq1201.100456.","journal-title":"Asterioscler Thromb Vasc Biol"},{"key":"870_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1006\/abbi.2001.2474","volume":"393","author":"CV Delgado-Reyes","year":"2001","unstructured":"Delgado-Reyes CV, Wallig MA, Garrow TA: Immuno-histochemical detection of betaine-homocysteine S-methyl-transferase in human, pig, and rat liver and kidney. Arch Biochem Biophys. 2001, 393: 184-186. 10.1006\/abbi.2001.2474.","journal-title":"Arch Biochem Biophys"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-12-117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-12-117\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-12-117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-12-117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:58:48Z","timestamp":1630533528000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-12-117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,28]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["870"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-12-117","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,28]]},"assertion":[{"value":"25 April 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"117"}}